Clinical trials
Phase 1 Gastrointestinal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 6 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Revolution Medicines, Inc. | 2 |
| Amsterdam UMC, location VUmc | 1 |
| Dr Anne Payne | 1 |
| Eveliqure Biotechnologies GmbH | 1 |
| Exeliom Biosciences | 1 |
| Federation Bio Inc. | 1 |
| HALEON | 1 |
| Hong Kong Baptist University | 1 |
| IDRX, Inc., a wholly owned subsidiary of GSK, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Diseases | 23 |
| Digestive System Diseases | 9 |
| Gastrointestinal Neoplasms | 5 |
| Intestinal Diseases | 5 |
| Digestive System Neoplasms | 4 |
| Neoplasms | 4 |
| Neoplasms by Site | 4 |
| Colonic Diseases | 3 |
| Inflammatory Bowel Diseases | 3 |
| Bronchial Neoplasms | 2 |
Trials
Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.